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Abstract The aim of this study is to investigate the short-
term renal function in neonates with twin-twin transfu-
sion syndrome (TTTS), treated with fetoscopic laser sur-
gery (laser group) or conservatively (non-laser group).
Creatinine and urea levels and urine output were record-
ed in the first week after birth. Primary outcome was
short-term renal dysfunction, defined as a creatinine level
of >100 μmol/L during the first week postpartum. We
evaluated 312 twins (laser group, n = 274; non-laser
group, n = 38). Median creatinine and urea levels were
lower in the laser group than in the non-laser group (71
versus 82 μmol/L, p = 0.002). Short-term renal dysfunc-
tion was lower in the laser group compared to the non-
laser group (7.2 versus 34.4%, p < 0.001). Within the
laser group, creatinine levels were significantly higher
in the subgroup with incomplete laser surgery compared
to twins with successful laser surgery (76 versus
69 μmol/L, p = 0.018). No differences were found be-
tween donors and recipients except for a higher incidence
of oliguria in donors in the non-laser group on day 1.
Conclusion: Short-term renal dysfunction occurs less fre-
quently in TTTS twins treated with fetoscopic laser coagula-
tion, particularly after complete surgery, suggesting that laser
surgery may have a protective effect on renal function.
What is Known:
• Antenatally, donor twins in TTTS have severe oliguria due to chronic
hypovolemia and impaired renal perfusion
• Postnatally, donor twins may suffer from severe renal complications,
particularly in TTTS twins treated conservatively.
What is New:
• The incidence of short-term renal failure in TTTS twins treated with
complete laser surgery is low.
• After incomplete laser surgery, the incidence of short-term renal dys-
function is increased.
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Introduction
Twin-twin transfusion syndrome (TTTS) is a serious compli-
cation that occurs in 10–15% of monochorionic twin pregnan-
cies and results from unbalanced inter-twin blood transfusion
through placental vascular anastomoses [1]. TTTS is detected
by prenatal ultrasound and is characterized by the presence of
polyhydramnios in the recipient twin due to hypervolemia and
polyuria, and oligohydramnios in the donor due to hypovole-
mia, renal hypoperfusion, and oliguria. TTTS can be treated
antenatally with serial amnioreduction, but the optimal treat-
ment is coagulation of the vascular anastomoses with
fetoscopic laser surgery [2]. Laser surgery is associated with
a significant reduction in perinatal morbidity and mortality
[3]. As a result of the increase in perinatal survival, attention
is now shifting toward short-term and long-term morbidity in
survivors. Several small studies in TTTS not treated with laser
surgery reported various renal complications in donor twins
after birth, caused by impaired renal perfusion, including his-
tological renal changes such as hypovascularisation and mi-
croangiopathy [4–8]. Whether postnatal renal dysfunction al-
so occurs in twins affected by TTTS treated with laser surgery
is not well known, as only few small studies have been pub-
lished to date [9, 10].
The aim of this retrospective study is to investigate the
short-term postnatal renal function in a large cohort of TTTS
twins treated with laser surgery (laser group), compared to a
group of TTTS twins treated conservatively with either serial
amnioreduction or expectant management (non-laser group)
and evaluate potential risk factors such as incomplete laser
surgery and donor status.
Methods
Data of all consecutive monochorionic twin pairs with TTTS,
born a t the Le iden Unive r s i t y Med ica l Cen te r
(The Netherlands) between July 2009 and June 2016, were
collected. The Leiden University Medical Center is a tertiary
care center and serves as the national referral center for
monochorionic twin pregnancies with TTTS.
TTTS was diagnosed using antenatal ultrasound, according
to the Eurofoetus criteria [2]. Pregnancies with intrauterine
death of one or both fetuses or twins with congenital anoma-
lies of the kidney and urinary tract were excluded.
Laser surgery was performed up to 26weeks of gestation in
all cases with stage 2 TTTS or higher and in cases with stage 1
associated with symptomatic polyhydramnios. All other cases
were treated conservatively with either serial amnioreduction
or expectant management.
Outcome of twins treated with laser surgery (laser group)
was compared to twins treated conservatively (non-laser
group) and between donors and recipients. In the laser group,
outcome was compared between twins with successful laser
surgery (complete laser group) and the twins with either re-
current or reversal of TTTS or post-laser twin anemia-
polycythemia sequence (TAPS) (incomplete laser group).
The following perinatal variables were recorded: gender,
mode of delivery, gestational age at birth, birth weight, and
birth weight difference between both twins. Birth weight dif-
ference was calculated as follows: ((birth weight larger
twin − birth weight smaller twin)/birth weight larger
twin) × 100.
At birth, blood pressure, heart rate, and hemoglobin levels
were routinely measured in all twins as standard of care. In
addition, creatinine and urea levels were routinely measured in
the first week after birth. Values measured in the first 2 days
after birth were excluded to reduce the influence of maternal
creatinine and urea. The highest value was included if more
than one value was measured. Urine output (in ml/kg/h) and
the presence of oliguria (urine output <1 ml/kg/h) during the
first 3 days after birth were recorded.
The following neonatal data were collected as well: hypo-
tension, respiratory distress syndrome (RDS), necrotizing en-
terocolitis (NEC), patent ductus arteriosus, sepsis, fetal dis-
tress, cerebral injury, and neonatal mortality. Hypotension
was defined as low blood pressure for which inotropic medi-
cation was given. Low blood pressure is defined as a mean
blood pressure lower than the gestational age. RDS was de-
fined as respiratory failure requiring respiratory support with
surfactant therapy. We recorded NEC in the case of ≥stage 2,
according to the Bell’s criteria. Cerebral injury was defined as
any of the following: cystic periventricular leukomalacia or
intraventricular hemorrhage grades 3–4. Sepsis was defined as
blood culture-proven sepsis or clinical sepsis (defined as a
clinically ill neonate with elevated infection parameters, re-
quiring antibiotic treatment, but without a positive blood cul-
ture). Fetal distress was defined as the presence of at least
three if the following criteria: decelerative cardiotocogram,
arterial umbilical cord pH < 7.10, 5-min Apgar score < 5,
spontaneous breathing > 5 min after birth, or multi-organ
failure.
The primary outcome in this study was short-term renal
dysfunction, defined as a creatinine level of >100 μmol/L
in the first week of life. We defined severe renal dysfunc-
tion as a creatinine level of >150 μmol/L. Secondary out-
comes were urine output and oliguria in the first 3 days of
life.
The local Medical Ethics Committee provided a state-
ment of no objection for obtaining and publishing the
anonymized data.
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Statistics
Data were reported as median and interquartile range (IQR).
Results of continuous variables between two groups were an-
alyzed using a Mann-Whitney U test. In order to compare
donors and recipients, we used the paired sample t test for
continuous variables and the Mc Nemar test for categorical
variables. Because of the limited sample size in the non-laser
group, a Fisher-Exact test was used for nominal variables.
Two-sided tests were used for statistical analyses, and a p
value <0.05 was considered statistically significant. All anal-
yses were performed using SPSS version 23 (SPSS, Inc.,
Chicago, Ill, USA).
Results
During the study period, 312 twins fulfilled the inclusion
criteria, of which 274 twins were treated with fetoscopic laser
surgery (laser group), and 38 twins were treated conservative-
ly (non-laser group) and managed either expectantly (n = 23)
or with serial amniodrainage (n = 15). The baseline character-
istics of the two studied groups are summarized in Table 1.
The gestational age at diagnosis of TTTS was 19 (17–22)
weeks in the laser group and 28 (26–29) weeks in the non-
laser group. TTTS staging at diagnosis was two (1–3) in the
laser group and one (1–3) in the non-laser group. In the laser
group, the median gestational age at laser surgery was 19 (17–
22) weeks.
Results of renal function in the laser group and non-laser
group are shown in Table 2. Creatinine and urea levels were
significantly lower in the laser group compared to the non-
laser group, respectively 71 versus 82 μmol/L (p = 0.002) and
5.2 versus 7.6 mmol/L (p < 0.001). Short-term renal dysfunc-
tion (creatinine level of >100 μmol/L) occurred less often in
the laser group (7.1%) compared to the non-laser group
(37.9%) (p < 0.001).
The incidence of oliguria was significantly lower in the
laser group, compared to the non-laser group, but only on
day 2.
Neonatal mortality and several perinatal and neonatal mor-
bidities occurred less frequently in the laser group compared
to the non-laser group, including hypotension and fetal dis-
tress, as shown in Table 3. Renal function was only in assessed
in two of the four neonates with a fetal distress, since two
neonates died within 24 h after birth.
Within the laser group, 228 had a successful laser surgery
(complete laser group) and 46 twin pairs had incomplete laser
surgery (post-laser TAPS, n = 36; recurrent or reversal TTTS,
n = 10), as shown in Table 2. The median creatinine level in
the complete laser subgroup was significantly lower
(69 μmol/L) compared to median creatinine level in the in-
complete laser group (76 μmol/L) (p = 0.018). The number of
neonates with a creatinine level of >100 μmol/L and the inci-
dence of oliguria was similar in both subgroups.
In the non-laser group, donor twins had more often oliguria
on day 1 (92.3 versus 20.0%, p = 0.001) and a lower mean
blood pressure (34 versus 47 mmHg, p = 0.031) compared to
their recipient co-twin.We found no other differences between
donors and recipients regarding other outcomes, including
short-term renal dysfunction, creatinine levels, and urea levels
(data not shown).
A creatinine level of >150 μmol/L was detected in 10 ne-
onates and occurred less often in the laser group than in the
non-laser group, respectively 1.1 (3/274) versus 18.4% (7/38)
(p < 0.001) and more often in donors (7/10) than recipients
(3/10). In the laser group, severely elevated creatinine levels
were detected in 4.4% (2/46) in the incomplete laser group and
in 0.4% (1/228) in the complete laser group. Neonatal mortal-
ity occurred in three of the ten neonates and was due to multi-
organ failure (n = 2) and respiratory failure including recurrent
Table 1 Baseline characteristics
in twins affected by TTTS treated
with laser surgery (laser group)
and treated conservatively (non-
laser group)
Laser group (na = 274) Non-laser group (na = 38)
TTTS stage at diagnosisb 2 (1–3)c 1 (1–3)d
TTTS stage 1—n (%) 72 (26.3%)c 16 (42.1%)d
Gestational age at diagnosis—weekb 19 (17–22)e 28 (26–29)d
Gestational age at birth—weekb 32 (30–34) 30 (29–34)
Cesarean section—no (%) 114 (41.6%) 30 (78.9%)
Female—no (%) 134 (48.9%) 14 (36.8%)
Birth weight—gb 1652 (1257–2046) 1548 (1039–2205)
Birth weight difference—%b 10.5 (5.2–20.6) 9.8 (8.1–21.7)
a Refers to the number of neonates
b Value given as median (IQR)
c 4.4% (12) missing
d 26% (10) missing
e 3.6% (10) missing
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bilateral tension pneumothorax and respiratory distress syn-
drome (n = 1). The highest creatinine level (347 μmol/L) was
detected in a donor twin in the non-laser group and was
thought to be due to acute tubular necrosis after severe chronic
renal hypoperfusion. Creatinine levels and renal function in
this donor twin normalized within several weeks after
Table 2 Renal function in the
laser group and non-laser group
and between the subgroup with
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UO urine output, MBP mean blood pressure, bpm beats per minute
a Refers to the number of neonates
b Value given as median (IQR)
c 38.6% (106) missing
d 23.7% (9) missing
e 0.8% (1) missing
f 10.8% (5) missing
g 1.8% (5) missing
h 43.9% (100) missing
i 38.0% (104) missing
j 39.5% (15) missing
k 42.1% (96) missing
l 17.4% (8) missing
m 39.8% (109) missing
n 34.2% (13) missing
o 48.5% (133) missing
p 36.8% (14) missing
q 50% (114) missing
r 19.6% (9) missing
s 19.3% (53) missing
t 13.2% (5) missing
u 23.2% (53) missing
v 13.1% (36) missing
w 15.8% (36) missing
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hyperhydration. Renal ultrasound showed nephrocalcinosis.
Urine calcium/creatinine ratio was not elevated, and on the
follow-up ultrasound at age 2, the nephrocalcinosis was barely
visible.
Discussion
This is the first study on short-term renal function in a large
cohort of TTTS twins treated with or without laser surgery,
assessing also the impact of incomplete laser treatment. We
found that the incidence of short-term renal failure in TTTS
twins treated with laser surgery is low. In contrast, the inci-
dence of renal failure and oliguria is increased in TTTS treated
conservatively or after incomplete laser surgery. Our findings
therefore suggest that laser surgery, when complete, may pro-
tect fetuses and neonates against renal injury. Although donor
twins suffer from severe oliguria and oligohydramnios, these
symptoms resolve after laser surgery (reflected by the reoc-
currence of amniotic fluid in the donor’s sac) antenatally and
detection of normal renal function in the vast majority of sur-
vivors after birth. However, long-term evaluation of renal
function in large TTTS cohorts is required to assess if the
protective effect is also present after the initial neonatal period.
A few small studies reported on the short-term and long-
term renal function in TTTS survivors after fetoscopic laser
surgery. Halvorsen et al. found a slightly higher incidence of
renal failure in a cohort of TTTS twins after laser surgery 10%
(9/87) compared to our cohort, but criteria for the renal dys-
function were not provided [11]. Lenclen et al. also reported a
similar risk of renal failure in TTTS twins after laser surgery
(7.1%, 7/98), but again, the definition of renal failure was not
specified, preventing comparisons with our findings. In addi-
tion, only preterm neonates delivered before 30 weeks of ges-
tation were included in this study [10].
Although our data suggest that the vast majority of TTTS
twins after laser surgery do not have short-term renal
dysfunction, a few neonates still had severely increased creat-
inine levels. This may partly be explained by the incomplete
laser surgery and persistence of inter-twin blood transfusion.
Whether the risk of renal dysfunction is also low on the long-
term is not well known, as this was evaluated only in one
small study from Beck et al. in 18 TTTS twins treated with
laser surgery. They found no evidence of renal failure at a
median age of 3 years; however, the sample size was too small
to reach firm conclusions [9]. Accurate renal follow-up should
take much longer. Due to the large reserve capacity of the
kidney, serum creatinine could be normal for a long time.
When children grow older and particularly during the growth
spurt, renal insufficiency might become evident [12].
In accordance with our findings, most studies in TTTS
twins not treated with laser report an increased risk of short-
term renal dysfunction, in particular in donor twins. In a pa-
thology study evaluating the renal anatomy in 25 TTTS twin
pairs after autopsy, De Paepe et al. found a loss of proximal
convoluted tubules in 48% of donors and 48% of recipients.
Although the glomerular density was higher in donor kidneys,
the number of glomerular generations was similar in donors
and recipients. The kidney weight of recipients was almost
twice as large of that of donor twins [5]. By comparison,
Oberg et al. reported in 8/9 donors varying degrees of tubular
deficiency [13], and Barr et al. reported varying degrees of
tubular deficiency in 11/21 donor kidneys (but in none of the
17 recipient twins) [8]. In a study by Chiang et al. in 22
neonates with TTTS, nine (41%) had acute renal failure (de-
fined as serum creatinine level above 1.5 mg/dL (133 μmol/L)
regardless of urine amount), of which the vast majority (8/9)
were donors [4]. In a study performed by our research group in
56 TTTS neonates treated conservatively, renal failure detect-
ed in two (4%) neonates, both donors, of which one died of
terminal renal failure. Definition of renal failure was not de-
scribed [14]. Cincotta et al. found an increased risk of renal
failure (defined as urine output <1 ml/kg/h during the first
3 days of life and high creatinine levels) in a small group of
Table 3 Clinical outcome in
TTTS twins in the laser group and
the non-laser group
Laser group (na = 274) Non-laser group (na = 38) P value
Hypotension—n (%) 12 (4.5%)b 8 (21.1%) 0.001
Cerebral injury—n (%) 8 (2.9%) 1 (2.7%)c 1.000
Necrotizing enterocolitis—n (%) 3 (1.1%)g 1 (2.6%) 0.408
Patent ductus arteriosus—n (%) 37 (13.5%) 10 (26.3%) 0.051
Sepsis—n (%) 25 (9.1%) 5 (13.5%)c 0.377
Fetal distress—n (%) 1 (0.4%)d 4 (11.1%)e 0.001
Mortality—n (%) 8 (2.9%) 5 (13.2%) 0.013
a Refers to the number of neonates
b 2.2% (6) missing
c 2.6% (1) missing
d 0.4% (1) missing
e 5.3% (2) missing
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TTTS twin pairs (n = 17) treated conservatively compared to
uncomplicated monochorionic twins (48 versus 15%,
p = 0.005), but no differences between donors and recipients
were found [15]. Lastly, Lenclen et al. also found an increased
incidence of renal failure in TTTS twins treated with
amniodrainage (20.0%, 6/30). However, no differences be-
tween donors and recipients were found.
In these studies, renal dysfunction which was detected
mainly in donors is thought to result mainly from chronic poor
renal perfusion and hypovolemia, in association of chronic
hypoxia and anemia [4, 10, 14, 15].
In our study, we also found a high risk of oliguria in donors
(>90%) in the non-laser group and a lower blood pressure at
birth, both probably reflecting the hypovolemic state of these
neonates at birth.
The ex-recipient, after complete laser surgery, has no renal
dysfunction due to good recovery in the antenatal period. In
case of incomplete laser surgery, the risk of renal dysfunction
is increased in both ex-donors and ex-recipients due to persis-
tent hemodynamic instability in utero. However, due to small
sample size and lack of power, the inter-twin differences in
this subgroup were not statistically significant.
The main limitation of this study is its retrospective design
and a selection bias between the conservative and the laser
group. The two groups differed in term of presenting charac-
teristics. The non-laser group was small and heterogeneous, as
it contained a mixture of TTTS cases with lower TTTS stages
and/or presentation at a later gestational age. Since TTTS in
the non-laser group was less severe, the incidence of renal
dysfunction in this subgroup was probably underestimated.
In contrast, the laser group in this study is very large and
homogeneous, limiting the risk of bias and supporting the
reliability of our findings. However, we included only TTTS
cases with double survivors at birth (to compare the outcome
within twin pairs); therefore, renal function in survivors after
single fetal demise requires further investigation. As recently
shown, single fetal demise in TTTS twins not treated with
laser can lead to severe renal ischemia and terminal renal
failure due to acute exsanguination through the vascular anas-
tomoses [16]. Since dichorionization of the placenta after
complete laser surgery prevents acute exsanguination, this se-
lection bias with double survivors may again have led to an
underestimation of the risk of renal failure in the non-laser
group. Another limitation is that other factors than TTTS
can influence renal function, such as being born at a younger
gestational age or hypotension. Unfortunately, due to the
small cohorts of the subgroups, the possibilities to perform
subgroup analysis and corrections for confounders are limited
and unreliable. Larger cohorts are needed to address these
pertinent questions. Finally, the assessment of short-term renal
function in this study was based only on routine measure-
ments at our neonatal nursery including urine production, cre-
atinine, and urea levels during the first week. More detailed
information on renal function would require different assess-
ments and a different study design.
In conclusion, our findings show that the risk of short-term
renal dysfunction in TTTS treated with laser surgery is low,
suggesting a protective effect of laser coagulation despite the
presence of severe oliguria and oligohydramnios in donor
twins during fetal life. Therefore, routine evaluation of renal
function after complete laser surgery in all survivors does not
seem warranted. In contrast, after incomplete laser surgery or
in TTTS treated conservatively, the risk of renal dysfunction is
increased, and postnatal renal evaluation should be recom-
mended. Future prospective research should focus on long-
term renal outcome in TTTS treated with and without laser
surgery to assess if the findings in the neonatal period persist
through childhood and adulthood.
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